Healthcare Outsourcing Industry - Analysis of Top 10 Trends

Table of Contents

Chapter 1. Executive Summary
1.1. Trends Ranking
1.2. Summarization chart
Chapter 2. Top 10 Trends - Broad-gauge Analysis
2.1. Consolidation/Divestures
2.1.1. List of mergers, by CROs/CMOs
2.1.2. List of acquisitions, by CROs/CMOs
2.1.3. List of divestures, by CROs/CMOs
2.1.4. List of partnerships, by CROs/CMOs
2.2. Decentralized/Hybrid Clinical Trials
2.2.1. Alternative technologies
2.2.1.1. Virtualization
2.2.1.2. In silico
2.2.2.虚拟化及其在商业操作mentation
2.2.2.1. Patient recruitment
2.2.2.2. Data management
2.3. Real World Data & Real-World Evidence
2.4. Growth of Biosimilars
2.4.1. R&D investments in Biosimilars
2.4.2.成本analysis of Biosimilar v/s other drugs
2.5. Genomics and Personalized Medication
2.5.1. Genomics in diabetes
2.5.2. Genomics in oncology
2.5.3. Genomics in neurovascular disorders
2.5.4. Genomics in cardiovascular disorders
2.6. Diversifying Geographical Footprints
2.6.1. Analysis of level of globalization
2.6.2. Regional presence of top 50 CROs & CMOs
2.6.3. Political pacts/policies impacting international business
2.7. Extended Reality
2.8. Decoupling of service offerings
2.8.1. Recent divestures
2.8.2. Value chain analysis
2.9. Capacity Expansion in Niche Markets
2.9.1. Analysis of current demand and supply
2.9.2. Focused capacity expansions since 2020 till 2023
2.10. Growth in Safety Assessment